[go: up one dir, main page]

AU2001289763A1 - Substituted and non-substituted benzooxathiazoles and compounds derived therefrom - Google Patents

Substituted and non-substituted benzooxathiazoles and compounds derived therefrom

Info

Publication number
AU2001289763A1
AU2001289763A1 AU2001289763A AU8976301A AU2001289763A1 AU 2001289763 A1 AU2001289763 A1 AU 2001289763A1 AU 2001289763 A AU2001289763 A AU 2001289763A AU 8976301 A AU8976301 A AU 8976301A AU 2001289763 A1 AU2001289763 A1 AU 2001289763A1
Authority
AU
Australia
Prior art keywords
substituted
benzooxathiazoles
derived therefrom
compounds derived
dioxides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289763A
Other languages
English (en)
Inventor
Karl-Heinz Baringhaus
Swen Holder
Guenter Mueller
Stefan Petry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Publication of AU2001289763A1 publication Critical patent/AU2001289763A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)
AU2001289763A 2000-08-09 2001-07-27 Substituted and non-substituted benzooxathiazoles and compounds derived therefrom Abandoned AU2001289763A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10038709 2000-08-09
DE10038709A DE10038709A1 (de) 2000-08-09 2000-08-09 Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen
PCT/EP2001/008704 WO2002011722A1 (fr) 2000-08-09 2001-07-27 Benzooxathiazoles substitues et non substitues et composes derives de ceux-ci

Publications (1)

Publication Number Publication Date
AU2001289763A1 true AU2001289763A1 (en) 2002-02-18

Family

ID=7651742

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289763A Abandoned AU2001289763A1 (en) 2000-08-09 2001-07-27 Substituted and non-substituted benzooxathiazoles and compounds derived therefrom

Country Status (13)

Country Link
US (3) US6566390B2 (fr)
EP (1) EP1311264B1 (fr)
JP (1) JP2004505916A (fr)
AT (1) ATE365552T1 (fr)
AU (1) AU2001289763A1 (fr)
CA (1) CA2418084C (fr)
CY (1) CY1107736T1 (fr)
DE (2) DE10038709A1 (fr)
DK (1) DK1311264T3 (fr)
ES (1) ES2284689T3 (fr)
MX (1) MXPA03000678A (fr)
PT (1) PT1311264E (fr)
WO (1) WO2002011722A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10038709A1 (de) * 2000-08-09 2002-02-28 Aventis Pharma Gmbh Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen
GB0227813D0 (en) * 2002-11-29 2003-01-08 Astrazeneca Ab Chemical compounds
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10334309A1 (de) * 2003-07-28 2005-03-03 Aventis Pharma Deutschland Gmbh Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
US7094794B2 (en) 2003-07-28 2006-08-22 Sanofi-Aventis Deutschland Gmbh Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
WO2005035551A2 (fr) 2003-10-08 2005-04-21 Incyte Corporation Inhibiteurs de proteines se liant a des molecules phosphorylees
DE102004026532A1 (de) 2004-05-29 2006-01-05 Sanofi-Aventis Deutschland Gmbh Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
CA2615774C (fr) * 2005-07-21 2014-12-09 Rensselaer Polytechnic Institute Opioides non phenoliques a large substitution
WO2008107699A1 (fr) * 2007-03-08 2008-09-12 Cambridge Enterprise Limited Diagnostic de troubles psychotiques
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
WO2012120053A1 (fr) * 2011-03-08 2012-09-13 Sanofi Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation
EP2766349B1 (fr) * 2011-03-08 2016-06-01 Sanofi Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
EP2683703B1 (fr) * 2011-03-08 2015-05-27 Sanofi Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, agent pharmaceutique contenant ces composés et leur utilisation
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2013078413A1 (fr) * 2011-11-22 2013-05-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulateurs du stockage lipidique

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539584A (en) * 1967-11-14 1970-11-10 Colgate Palmolive Co 5-substituted-2,1-benzisothiazolines
DE3311636A1 (de) * 1983-03-30 1984-10-04 Bayer Ag, 5090 Leverkusen Neue fuenfgliedrige stickstoffhaltige heterocyclen, verfahren zu ihrer herstellung sowie ihre verwendung als schaedlingsbekaempfungsmittel
JPH04128276A (ja) 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
US5504095A (en) * 1990-09-19 1996-04-02 Pfizer Inc. Aminobenzosultam derivatives as lipoxygenase inhibitors
US5130432A (en) * 1990-12-21 1992-07-14 Syntex (U.S.A.) Inc. Process for preparing cyclic amines and intermediate products thereof
EP0549348A1 (fr) * 1991-12-24 1993-06-30 PHARMACIA S.p.A. Dérivés arylidène-hétérocycliques, procédé de préparation et utilisation comme inhibiteurs de tyrisine kinase
CN1073563C (zh) * 1994-04-11 2001-10-24 中外制药株式会社 4,6－二叔丁基－2,3－二氢苯并噻吩衍生物
JPH07325942A (ja) 1994-05-31 1995-12-12 Mitsubishi Heavy Ind Ltd カード類処理装置
WO1995033746A1 (fr) * 1994-06-08 1995-12-14 E.I. Du Pont De Nemours And Company Sulfonamides cycliques herbicides
WO1997003974A2 (fr) 1995-07-20 1997-02-06 Basf Aktiengesellschaft Derives de chromane, leur production et leur utilisation comme stabilisateurs de matieres organiques contre l'effet de la lumiere, l'oxygene et la chaleur
US5874382A (en) * 1996-11-13 1999-02-23 E. I. Du Pont De Nemours And Company Cyclic sulfonamide herbicides
US5929250A (en) * 1997-01-23 1999-07-27 Smithkline Beecham Corporation IL-8 receptor antagonists
AR008331A1 (es) * 1997-01-23 1999-12-29 Smithkline Beecham Corp Compuestos antagonistas de un receptor de il-8, uso de los mismos para la fabricacion de medicamentos, procedimiento para su obtencion, composicionesfarmaceuticas que los contienen
TR199901710T2 (xx) * 1997-01-23 1999-09-21 Smithkline Beecham Corporation IL-8 resept�r antagonistleri.
DE19738005A1 (de) * 1997-08-30 1999-03-04 Bayer Ag Verwendung von substituierten 1,1-Bisphosphonaten
AR015425A1 (es) * 1997-09-05 2001-05-02 Smithkline Beecham Corp Compuestos de benzotiazol, composicion farmaceutica que los contiene, su uso en la manufactura de un medicamento, procedimiento para su preparacion,compuestos intermediarios y procedimiento para su preparacion
AR015426A1 (es) * 1997-09-05 2001-05-02 Smithkline Beecham Corp Compuestos de benzotiazol antagonistas del receptor de il-8, composicion farmaceutica que los contiene, su uso para la manufactura de un medicamento,procedimiento para su preparacion, compuestos intermediarios y procedimiento para su preparacion
AU2234199A (en) * 1998-01-16 1999-08-02 Smithkline Beecham Corporation Il-8 receptor antagonists
WO1999046237A1 (fr) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulateurs de proteine-tyrosine-phosphatases
US6001867A (en) * 1998-05-12 1999-12-14 American Home Products Corporation 1-aryl-dibenzothiophenes
EP1098884A4 (fr) * 1998-07-23 2003-01-22 Smithkline Beecham Corp Antagonistes de recepteur d'il-8
WO2000006557A1 (fr) * 1998-07-27 2000-02-10 Smithkline Beecham Corporation Nouveau procede de fabrication d'antagonistes du recepteur il-8
JP2002527446A (ja) * 1998-10-14 2002-08-27 バーゼル、ポリプロピレン、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング 固定した架橋を有するメタロセン
US6339098B1 (en) * 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6319912B1 (en) * 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
DE10038709A1 (de) * 2000-08-09 2002-02-28 Aventis Pharma Gmbh Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen

Also Published As

Publication number Publication date
CY1107736T1 (el) 2013-04-18
US7211592B2 (en) 2007-05-01
PT1311264E (pt) 2007-07-31
ES2284689T3 (es) 2007-11-16
US20030191161A1 (en) 2003-10-09
US6566390B2 (en) 2003-05-20
WO2002011722A1 (fr) 2002-02-14
ATE365552T1 (de) 2007-07-15
JP2004505916A (ja) 2004-02-26
DE50112671D1 (de) 2007-08-09
DK1311264T3 (da) 2007-09-10
EP1311264B1 (fr) 2007-06-27
US20020055523A1 (en) 2002-05-09
DE10038709A1 (de) 2002-02-28
CA2418084A1 (fr) 2003-02-04
MXPA03000678A (es) 2003-06-06
CA2418084C (fr) 2010-03-30
US20050043373A1 (en) 2005-02-24
EP1311264A1 (fr) 2003-05-21

Similar Documents

Publication Publication Date Title
CY1107736T1 (el) Υποκατεστημενα και μη υποκατεστημενα βενζοξαθειαζολια, ως και εκπορευομενες απο αυτα ενωσεις
HUP0204242A3 (en) Novel 1,3-dihydro-2h-indol-2-one derivatives, their preparation and pharmaceutical compositions compositions containing them
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
EP1589017A3 (fr) Dérivés d'épothilone modifiés en position 12,13
HUP0400636A3 (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
HK1047283A1 (zh) 以四羥基喹啉葎基(tetrahydroquinolinyl)、芳基或雜芳基和烷基取代的具有視網膜樣的生物活性的胺類
AU2002223127A1 (en) Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
ZA200000603B (en) Use of stilbene derivatives substituted in position 3, as deodrorant active agents in cosmetic compositions.
CA2163837A1 (fr) Hydrates de paclitaxel cristallises
AU2002258971A1 (en) Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
EP1900802A3 (fr) Savon de toilette renfermant un acidifiant latent
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
AU2001269063A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
IL126296A0 (en) Benzopyran derivatives having leukotriene antagonistic action
EP2017269A3 (fr) Composition pharmaceutique comprenant forme cristalline II de Ritonavir et procédé de sa préparation
CA2327784A1 (fr) Triazolones a effet neuroprotecteur
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
IL147978A0 (en) Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists
CA2399709A1 (fr) Utilisation d'acide 2-methyl-thiazolidin-2,4-dicarboxylique (2-mtdc) et/ou de ses sels physiologiquement compabibles pour le traitement et/ou la prevention de cancers
HUP9800395A3 (en) Sulfonamide-substituted benzoxepine derivatives, their use as medicines and pharmaceutical compositions containing them
ZA200110244B (en) Novel xanthone compounds, their preparation and use as medicament.
AU2002303529A1 (en) Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
ITMI20000293A0 (it) Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica
IL156174A (en) 1,2,4-oxadiazole derivatives and pharmaceutical compositions containing them
IL162350A0 (en) Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives